STAT+: Pharmalittle: Pfizer plans to quadruple price of its Covid-19 vaccine; pharma pushed to tie exec compensation to access to meds
Pfizer expects to quadruple the list price of its Covid-19 vaccine to about $110 to $130 per dose after the U.S. government purchase program expires.
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream
